publication venue for
- T cell states, repertoire and function in classical Hodgkin lymphoma revealed through single-cell analyses. 2024
- Immune-related colitis is associated with fecal microbial dysbiosis and can be mitigated by fecal microbiota transplantation. 2023
- Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium. 2023
- Host Interactions with Engineered T-cell Micropharmacies.. 11. 2023
- Tumor-targeted non-ablative radiation promotes solid tumor CAR T-cell therapy efficacy. 2023
- Regulation of PD-L1 Trafficking from Synthesis to Degradation. 2023
- T cell-Mediated Development of Stromal Fibroblasts with an Immune-Enhancing Chemokine Profile. 2023
- T cell-mediated development of stromal fibroblasts with an immune-enhancing chemokine profile. 2023
- Translating Science into Survival: Report on the Sixth International Cancer Immunotherapy Conference.. 11. 2023
- BCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-II.. 10. 2022
- Harnessing Microbiota to Improve Immunotherapy for Gastrointestinal Cancers. 2022
- Microenvironmental landscape of human melanoma brain metastases in response to immune checkpoint inhibition. 2022
- Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment.. 10. 2022
- Hallmarks of Resistance to Immune-Checkpoint Inhibitors.. 10. 2022
- Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma.. 10. 2022
- Myeloid-Derived Suppressor Cells and Radiotherapy. 10:545-557. 2022
- The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.. 9. 2021
- TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma.. 9. 2021
- Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses. 2021
- Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.. 9. 2020
- Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.. 8. 2020
- Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.. 8. 2020
- Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells.. 8. 2020
- Optimization of T-cell Receptor-Modified T Cells for Cancer Therapy.. 8. 2020
- Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.. 8. 2020
- CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection.. 8. 2020
- Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary Intervention.. 8. 2019
- Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer.. 8. 2019
- Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma.. 8. 2019
- Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency.. 7. 2019
- ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.. 7. 2019
- SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer.. 7. 2019
- Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma.. 7. 2019
- Tumor Lymphatic Function Regulates Tumor Inflammatory and Immunosuppressive Microenvironments.. 7. 2019
- Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.. 6. 2018
- Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies.. 6. 2018
- Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.. 6. 2018
- Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.. 6. 2018
- The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma.. 6. 2018
- PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF.. 6. 2018
- TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.. 6. 2018
- Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade.. 6. 2018
- Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.. 6. 2017
- Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.. 5. 2017
- Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.. 5. 2017
- Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.. 5. 2017
- Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade.. 5. 2016
- Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.. 5. 2016
- Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.. 4. 2016
- Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.. 4. 2016
- Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups.. 4. 2016
- Antitumor Efficacy of Anti-GD2 IgG1 Is Enhanced by Fc Glyco-Engineering.. 4. 2016
- Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.. 4. 2016
- T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy.. 4. 2015
- Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.. 3. 2015
- MicroRNA MIR21 and T Cells in Colorectal Cancer.. 4. 2015
- Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation.. 3. 2015
- Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma.. 3. 2015
- Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases.. 3. 2015
- Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.. 3. 2015
- Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody.. 3. 2014
- A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.. 2. 2014
- Phenotypic and functional activation of hyporesponsive KIRnegNKG2Aneg human NK-cell precursors requires IL12p70 provided by Poly(I:C)-matured monocyte-derived dendritic cells.. 2. 2014
- CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.. 2. 2014
- IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.. 2. 2014
- Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.. 2. 2014
- Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.. 2. 2014
- Cancer-testis antigen 7 expression and immune responses following allogeneic stem cell transplantation for multiple myeloma.. 2. 2014
- The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance.. 2. 2014
- Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.. 2. 2014
- Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.. 2. 2014
- Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.. 2. 2014
- Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.. 2. 2014
- Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor.. 2. 2014
- Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1.. 2. 2013
- Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions.. 2. 2013
- GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability.. 1. 2013
- Effect of Montanide and poly-ICLC adjuvant on human self/tumor antigen-specific CD4+ T cells in phase I overlapping long peptide vaccine trial.. 1. 2013
- Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy.. 1. 2013
- Tales of Antigen Evasion from CAR Therapy. 2016
- De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute. 2016
- Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma. 2013
- Regulatory T Cells: Differentiation and Function. 2016